Health and Healthcare

Gilead Sciences : GILD

All Gilead Sciences Articles

732 Articles

Jon C. Ogg | Dec 20, 2012 at 6:21 AM EST

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Thinkstock24/7 Wall St. is looking for the next great biotech stocks for 2013 after great gains have been seen in…

Jon C. Ogg | Dec 12, 2012 at 3:54 PM EST

Massive Insider Selling Already Happening Before Higher Capital Gains Taxes Kick In

ThinkstockInsider selling is starting to get massive before year-end when higher capital gains taxes will kick in. We continue to…

247sam | Dec 12, 2012 at 10:54 AM EST

Today’s Market Winners and Losers

The stock market is mixed Wednesday, with the Dow Jones Industrial Average up 0.06%, the Nasdaq down 0.03% and the…

Jon C. Ogg | Dec 5, 2012 at 4:28 PM EST

Stocks to Buy: Fortune’s 10 Picks for 2013 (ALGN, PNR, GILD, MCO, PAY, USB, F, CMCSA, UL, FMS)

Fortune is out with its top 10 stock picks for 2013. The list was divulged on CNBC late on Wednesday…

Jon C. Ogg | Dec 5, 2012 at 1:07 PM EST

The 10 Best S&P 500 Stocks of 2012 (PHM, S, WHR, EXPE, LEN, MPC, GILD, BAC, TSO, STZ)

The list of the best stocks of 2012 on the S&P 500 Index is one which makes sense in some…

247sam | Nov 12, 2012 at 11:12 AM EST

Today’s Market Winners and Losers

The stock market is down Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq down 0.02% and the…

Jon C. Ogg | Nov 12, 2012 at 9:03 AM EST

Gilead Sciences and Celgene Score Major Drug Wins

ThinkstockWhen biotech stocks become as big as some of the second-tier drug stocks, it represents billions of dollars worth of…

Trey Thoelcke | Nov 12, 2012 at 8:04 AM EST

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke | Oct 25, 2012 at 7:41 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke | Oct 11, 2012 at 8:25 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September…

Trey Thoelcke | Sep 26, 2012 at 8:53 AM EDT

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short…

Jon C. Ogg | Sep 17, 2012 at 3:16 PM EDT

BofA Adds GE, Gilead, Regions and Valero to Most Attractive Buy List

Key research changes have been made in the last few days over at Bank of America/Merrill Lynch’s research coverage. The…

Trey Thoelcke | Sep 13, 2012 at 8:52 AM EDT

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date…

Douglas A. McIntyre | Aug 28, 2012 at 6:32 AM EDT

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Apple Inc. (NASDAQ: AAPL) pushes for a ban on eight Samsung phones. (Reuters) Best Buy Co. Inc. (NYSE: BBY) will…

Trey Thoelcke | Aug 27, 2012 at 8:10 AM EDT

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date…

1 … 41 42 43 44 45 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Massive Insider Selling Already Happening Before Higher Capital Gains Taxes Kick In

Today’s Market Winners and Losers

Stocks to Buy: Fortune’s 10 Picks for 2013 (ALGN, PNR, GILD, MCO, PAY, USB, F, CMCSA, UL, FMS)

The 10 Best S&P 500 Stocks of 2012 (PHM, S, WHR, EXPE, LEN, MPC, GILD, BAC, TSO, STZ)

Today’s Market Winners and Losers

Gilead Sciences and Celgene Score Major Drug Wins

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

BofA Adds GE, Gilead, Regions and Valero to Most Attractive Buy List

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

Gilead Sciences : GILD

All Gilead Sciences Articles

Nine Big Expected Biotech Winners for 2013 (ARIA, CBST, INCY, JAZZ, MDVN, ONXX, THRX, VPHM, VVUS)

Massive Insider Selling Already Happening Before Higher Capital Gains Taxes Kick In

Today’s Market Winners and Losers

Stocks to Buy: Fortune’s 10 Picks for 2013 (ALGN, PNR, GILD, MCO, PAY, USB, F, CMCSA, UL, FMS)

The 10 Best S&P 500 Stocks of 2012 (PHM, S, WHR, EXPE, LEN, MPC, GILD, BAC, TSO, STZ)

Today’s Market Winners and Losers

Gilead Sciences and Celgene Score Major Drug Wins

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

BofA Adds GE, Gilead, Regions and Valero to Most Attractive Buy List

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

‘You’re Gonna Go Into Retirement Broke and Wait on Mom to Die’: Dave Ramsey’s Reality Check for a Caller Eyeing His Inheritance

“You Don’t Want to Pass the Burden of Investments Down to Your Daughter”: Suze Orman’s Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings

EEM’s 0.69% Fee Quietly Costs You $690 a Year, but Your Cheaper Alternative Charges $90

Featured Reads

'You're Gonna Go Into Retirement Broke and Wait on Mom to Die': Dave Ramsey's Reality Check for a Caller Eyeing His Inheritance

"You Don't Want to Pass the Burden of Investments Down to Your Daughter": Suze Orman's Advice to a 78-Year-Old With a Disabled Heir and $111K in Savings